Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD B.A. Priego-Parra; A. Triana-Romero; R. Bernal-Reyes; M.E. Icaza-Chávez; S.E. Martínez-Vázquez; M. Amieva-Balmori; A.D. Cano-Contreras; H. Vivanco-Cid; J.M. Remes-Troche;

Adjusted prevalence of metabolic-associated steatotic liver disease (MASLD) in a Mexican R. Bernal-Reyes R; B.A. Priego-Parra; M.E. Icaza-Chávez; J.M. Remes-Troche;

Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study R. Bernal-Reyes; M.E. Icaza-Chávez; L.A. Chi-Cervera; J.M. Remes-Troche; M. Amieva-Balmori; B.A. Priego-Parra; S. Martínez-Vázquez; I.O. Méndez-Guerrero; L. Martínez-Rodríguez; A. Barranca-Enríquez; C. Palmeros-Exsome; A.D. Cano-Contreras; A. Triana-Romero;